J. Jobsen

发表

Long-term improvement in treatment outcome after radiotherapy and hyperthermia in locoregionally advanced cervix cancer: an update of the Dutch Deep Hyperthermia Trial.

Martine Franckena, Gerard C van Rhoon, Lukas J A Stalpers, 2008, International journal of radiation oncology, biology, physics.

Clinical relevance of the timing of radiotherapy after breast-conserving surgery

J. van der Palen, H. Struikmans, J. Jobsen, 2021, Strahlentherapie und Onkologie.

year survival after breast-conserving surgery plus radiotherapy compared with mastectomy in early breast cancer in the Netherlands : a population-based study

S. Linn, S. Siesling, L. Strobbe, 2016 .

Sequence of radiotherapy and chemotherapy in breast cancer after breast-conserving surgery.

F. Ong, M. Brinkhuis, J. van der Palen, 2012, International journal of radiation oncology, biology, physics.

Adjuvant chemoradiotherapy versus radiotherapy alone for women with high-risk endometrial cancer (PORTEC-3): final results of an international, open-label, multicentre, randomised, phase 3 trial

H. Putter, C. Haie-meder, H. Kitchener, 2018, The Lancet. Oncology.

Endometrium FIFTEEN-YEAR RADIOTHERAPY OUTCOMES OF THE RANDOMIZED PORTEC-1 TRIAL FOR ENDOMETRIAL CARCINOMA

Rémi, L. V. van de Poll-Franse, W. van Putten, 2011 .

Surgery and postoperative radiotherapy versus surgery alone for patients with stage-1 endometrial carcinoma: multicentre randomised trial

P. Koper, W. Putten, C. Wárlám-Rodenhuis, 2000, The Lancet.

The morbidity of treatment for patients with Stage I endometrial cancer: results from a randomized trial.

P. Koper, E. M. van der Steen-Banasik, W. van Putten, 2001, International journal of radiation oncology, biology, physics.

Radiotherapy and hyperthermia for treatment of primary locally advanced cervix cancer: results in 378 patients.

J. van der Zee, P. Koper, G. V. van Rhoon, 2009, International journal of radiation oncology, biology, physics.

Long-term effects of first degree family history of breast cancer in young women: Recurrences and bilateral breast cancer

F. Ong, M. Brinkhuis, J. van der Palen, 2016, Acta oncologica.

Surgery and postoperative radiotherapy versus surgery alone for patients with stage-1 endometrial carcinoma: multicentre randomised trial. PORTEC Study Group. Post Operative Radiation Therapy in Endometrial Carcinoma.

P. Koper, C. Wárlám-Rodenhuis, C. Creutzberg, 2000 .

Long-term prognosis of patients with local recurrence after conservative surgery and radiotherapy for early breast cancer.

M. J. van de Vijver, J. Peterse, J. Coebergh, 2005, European journal of cancer.

The value of a positive margin for invasive carcinoma in breast-conservative treatment in relation to local recurrence is limited to young women only.

F. Ong, J. van der Palen, J. Jobsen, 2003, International journal of radiation oncology, biology, physics.

Carcinoma of the esophagus: treatment results.

W. van Putten, W. Eijkenboom, J. Jobsen, 1986, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Effect of physical exercise on cognitive function after chemotherapy in patients with breast cancer: a randomized controlled trial (PAM study)

M. D. de Ruiter, D. Sommeijer, A. May, 2022, Breast Cancer Research.

Substantial lymph-vascular space invasion (LVSI) is a significant risk factor for recurrence in endometrial cancer--A pooled analysis of PORTEC 1 and 2 trials.

T. Bosse, E. M. van der Steen-Banasik, V. Smit, 2015, European journal of cancer.

Synchronous, bilateral breast cancer: prognostic value and incidence.

F. Ong, J. van der Palen, J. Jobsen, 2003, Breast.

Limited Impact of Breast Cancer and Non-breast Malignancies on Survival in Older Patients with Early-Stage Breast Cancer: Results of a Large, Single-Centre, Population-Based Study.

J. van der Palen, H. Struikmans, J. Jobsen, 2021, Clinical oncology (Royal College of Radiologists (Great Britain)).

Breast-conserving therapy in older patients with breast cancer over three decades: progress or stagnation.

S. Siesling, J. van der Palen, H. Struikmans, 2019, Journal of geriatric oncology.

Local recurrence after breast conservation therapy for early stage breast carcinoma: detection, treatment, and outcome in 266 patients. Dutch Study Group on Local Recurrence after Breast Conservation (BORST).

J. Coebergh, E. Rutgers, H. Peterse, 1999, Cancer.

Survival after relapse in patients with endometrial cancer: results from a randomized trial.

P. Koper, E. M. van der Steen-Banasik, W. van Putten, 2003, Gynecologic oncology.

Effect of external boost volume in breast-conserving therapy on local control with long-term follow-up.

F. Ong, J. van der Palen, J. Jobsen, 2008, International journal of radiation oncology, biology, physics.

The clinical relevance of various methods of classifying ipsilateral breast tumour recurrence as either true local recurrence or new primary

J. van der Palen, H. Struikmans, J. Jobsen, 2022, Breast Cancer Research and Treatment.

In reply to D. N. Sharma et al.

H. Struikmans, J. Jobsen, 2013, International journal of radiation oncology, biology, physics.

Family history in breast cancer is not a prognostic factor?

J. van der Palen, J. Jobsen, J. Meerwaldt, 2000, Breast.

Effect of physical exercise on cognitive function after chemotherapy in patients with breast cancer: a randomized controlled trial (PAM study)

M. D. de Ruiter, A. May, E. van der Wall, 2021, Breast cancer research : BCR.

Postoperative radiotherapy for Stage 1 endometrial carcinoma: long-term outcome of the randomized PORTEC trial with central pathology review.

P. Koper, W. van Putten, V. Smit, 2005, International journal of radiation oncology, biology, physics.

Microcystic elongated and fragmented (MELF) pattern of invasion: Molecular features and prognostic significance in the PORTEC-1 and -2 trials.

T. Bosse, E. M. van der Steen-Banasik, V. Smit, 2022, Gynecologic oncology.

Long-Term Impact of Endometrial Cancer Diagnosis and Treatment on Health-Related Quality of Life and Cancer Survivorship: Results From the Randomized PORTEC-2 Trial.

H. Putter, S. Oerlemans, E. M. van der Steen-Banasik, 2015, International journal of radiation oncology, biology, physics.

Five-year quality of life of endometrial cancer patients treated in the randomised Post Operative Radiation Therapy in Endometrial Cancer (PORTEC-2) trial and comparison with norm data.

H. Putter, L. V. van de Poll-Franse, E. M. van der Steen-Banasik, 2012, European journal of cancer.

Long-term impact of endometrial cancer diagnosis and treatment on health-related quality of life and cancer survivorship

H. Putter, S. Oerlemans, I. Jürgenliemk-Schulz, 2022 .

Vaginal brachytherapy versus external beam pelvic radiotherapy for high-intermediate risk endometrial cancer: Results of the randomized PORTEC-2 trial

H. Putter, I. Jürgenliemk-Schulz, A. Slot, 2008 .

Pattern of ipsilateral breast tumor recurrence after breast-conserving therapy.

F. Ong, J. van der Palen, H. Struikmans, 2014, International Journal of Radiation Oncology, Biology, Physics.

Prognostic refinement of NSMP high-risk endometrial cancers using oestrogen receptor immunohistochemistry

C. Genestie, H. Mackay, A. Fyles, 2022, British Journal of Cancer.

Defining Substantial Lymphovascular Space Invasion in Endometrial Cancer

T. Bosse, E. M. van der Steen-Banasik, V. Smit, 2021, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.

L1 cell adhesion molecule is a strong predictor for distant recurrence and overall survival in early stage endometrial cancer: pooled PORTEC trial results.

T. Bosse, V. Smit, I. Jürgenliemk-Schulz, 2014, European journal of cancer.

The morbidity of treatment for patients with stage I endometrial cancer: results from a randomized trial

P. Koper, A.C.M. van den Bergh, W. Putten, 2002 .

Treatment of locoregional recurrence of carcinoma of the cervix by radiotherapy after primary surgery.

J. Hermans, J. Leer, J. Jobsen, 1989, Gynecologic oncology.

10 year survival after breast-conserving surgery plus radiotherapy compared with mastectomy in early breast cancer in the Netherlands: a population-based study.

S. Linn, S. Siesling, L. Strobbe, 2016, The Lancet. Oncology.

Improved risk assessment of endometrial cancer by combined analysis of MSI, PI3K-AKT, Wnt/β-catenin and P53 pathway activation.

Tjalling Bosse, T. Bosse, N. T. Ter Haar, 2012, Gynecologic oncology.

Bilateral breast cancer, synchronous and metachronous; differences and outcome

H. Struikmans, F. Ong, H. Struikmans, 2015, Breast Cancer Research and Treatment.

Phase III randomised study to evaluate the role of adjuvant pelvic radiotherapy in the treatment of uterine sarcomas stages I and II: an European Organisation for Research and Treatment of Cancer Gynaecological Cancer Group Study (protocol 55874).

M. Franchi, I. Vergote, A. Poveda, 2008, European journal of cancer.

Improved Risk Assessment by Integrating Molecular and Clinicopathological Factors in Early-stage Endometrial Cancer—Combined Analysis of the PORTEC Cohorts

H. Putter, T. Bosse, E. M. van der Steen-Banasik, 2016, Clinical Cancer Research.

Prognostic Significance of POLE Proofreading Mutations in Endometrial Cancer

D. Lambrechts, I. Tomlinson, P. Wild, 2014, Journal of the National Cancer Institute.

Breast Cancer Survival of BRCA1/BRCA2 Mutation Carriers in a Hospital-Based Cohort of Young Women

R. Tollenaar, M. Schmidt, A. Jager, 2017, Journal of the National Cancer Institute.

The impact of margin status in breast-conserving therapy for lobular carcinoma is age related.

F. Ong, J. van der Palen, H. Struikmans, 2010, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Local recurrence after breast conservation therapy for early stage breast carcinoma

J. Coebergh, E. Rutgers, H. Peterse, 1999 .

The impact of age on local control in women with pT1 breast cancer treated with conservative surgery and radiation therapy.

J. van der Palen, J. Jobsen, J. Meerwaldt, 2001, European journal of cancer.

Quality of life after pelvic radiotherapy or vaginal brachytherapy for endometrial cancer: first results of the randomized PORTEC-2 trial.

Hein Putter, H. Putter, E. M. van der Steen-Banasik, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Interpretable deep learning model to predict the molecular classification of endometrial cancer from haematoxylin and eosin-stained whole-slide images: a combined analysis of the PORTEC randomised trials and clinical cohorts.

H. Mackay, J. Dijkstra, T. Bosse, 2022, The Lancet. Digital health.

Prognostic Integrated Image-Based Immune and Molecular Profiling in Early-Stage Endometrial Cancer

K. Mertz, T. Bosse, E. M. van der Steen-Banasik, 2020, Cancer Immunology Research.

Ten-year results of the PORTEC-2 trial for high-intermediate risk endometrial carcinoma: improving patient selection for adjuvant therapy

H. Putter, T. Bosse, B. van Triest, 2018, British Journal of Cancer.

Long-term outcome and quality of life of patients with endometrial carcinoma treated with or without pelvic radiotherapy in the post operative radiation therapy in endometrial carcinoma 1 (PORTEC-1) trial.

Lonneke V van de Poll-Franse, L. V. van de Poll-Franse, W. van Putten, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Outcome of Endometrial Cancer Stage IIIA with Adnexa or Serosal Involvement Only

S. Siesling, E. M. van der Steen-Banasik, J. van der Palen, 2011, Obstetrics and gynecology international.

Multicenter cohort study on treatment results and risk factors in stage II endometrial carcinoma

S. Siesling, E. M. van der Steen-Banasik, J. van der Palen, 2007, International Journal of Gynecologic Cancer.

Nomograms for prediction of outcome with or without adjuvant radiation therapy for patients with endometrial cancer: a pooled analysis of PORTEC-1 and PORTEC-2 trials.

P. Lambin, V. Smit, R. V. van Stiphout, 2015, International journal of radiation oncology, biology, physics.

No Increased Risk of Second Cancer After Radiotherapy in Patients Treated for Rectal or Endometrial Cancer in the Randomized TME, PORTEC-1, and PORTEC-2 Trials.

Cornelis J H van de Velde, Marta Fiocco, I. Nagtegaal, 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

The prognostic relevance of the mitotic activity index in axillary lymph node-negative breast cancer

J. Nortier, M. Brinkhuis, H. Struikmans, 2014, Breast Cancer Research and Treatment.

Surgery and postoperative radiotherapy vs. surgery alone for patients with endometrial cancer: multicenter randomized trial Portec Study Group

W. Putten, C. Wárlám-Rodenhuis, C. Creutzberg, 2000 .

The number of metastatic sites for stage IIIA endometrial carcinoma, endometrioid cell type, is a strong negative prognostic factor.

S. Siesling, E. M. van der Steen-Banasik, J. van der Palen, 2010, Gynecologic oncology.

Survival after relapse in patients with endometrial cancer: results from a randomized trial

P. Koper, A.C.M. van den Bergh, W. Putten, 2001 .

Impact of Age at Primary Breast Cancer on Contralateral Breast Cancer Risk in BRCA1/2 Mutation Carriers.

A. Broeks, R. Tollenaar, M. Schmidt, 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Effect of physical exercise on the hippocampus and global grey matter volume in breast cancer patients: A randomized controlled trial (PAM study)

M. D. de Ruiter, R. Mandl, D. Sommeijer, 2022, NeuroImage: Clinical.

Prevalence and Prognosis of Lynch Syndrome and Sporadic Mismatch Repair Deficiency in Endometrial Cancer

H. Putter, T. Bosse, L. Mileshkin, 2021, Journal of the National Cancer Institute.

Therapy of esophageal carcinoma. Results from the Joint Group on Esophageal Carcinoma in Rotterdam.

W. van Putten, W. Eijkenboom, J. Jobsen, 1986, Acta radiologica. Oncology.

Effect of physical exercise on cognitive function and brain measures after chemotherapy in patients with breast cancer (PAM study): protocol of a randomised controlled trial

P. Peeters, M. D. de Ruiter, A. May, 2019, BMJ Open.

Increased risks of third primary cancers of non-breast origin among women with bilateral breast cancer

J. Coebergh, I. Soerjomataram, S. Siesling, 2012, British Journal of Cancer.

Course of Quality of Life After Radiation Therapy for Painful Bone Metastases: A Detailed Analysis From the Dutch Bone Metastasis Study.

F. Oort, C. Marijnen, Y. M. van der Linden, 2016, International journal of radiation oncology, biology, physics.

Differences in outcome for positive margins in a large cohort of breast cancer patients treated with breast-conserving therapy

F. Ong, J. van der Palen, J. Jobsen, 2007, Acta oncologica.

The influence of timing of radiation therapy following breast-conserving surgery on 10-year disease-free survival

C. Groothuis-Oudshoorn, S. Siesling, L. Strobbe, 2017, British Journal of Cancer.

Factors influencing time between surgery and radiotherapy: A population based study of breast cancer patients.

S. Siesling, J. Maduro, H. Struikmans, 2015, Breast.

Use of primary radiotherapy for rectal cancer in the Netherlands between 1997 and 2008: a population-based study.

J. Coebergh, C. Koning, S. Siesling, 2012, Clinical oncology (Royal College of Radiologists (Great Britain)).

An increased utilisation rate and better compliance to guidelines for primary radiotherapy for breast cancer from 1997 till 2008: a population-based study in the Netherlands.

C. Koning, L. Veerbeek, J. Immerzeel, 2011, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

A population-based study on the utilisation rate of primary radiotherapy for prostate cancer in 4 regions in the Netherlands, 1997-2008.

J. Coebergh, C. Koning, H. Struikmans, 2011, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

5000 ORAL Quality of life after radiotherapy for endometrial cancer: first results from the randomized PORTEC-2 trial

H. Putter, R. Nout, A. Slot, 2007 .

Automated causal inference in application to randomized controlled clinical trials pdf

Viktor H. Koelzer, Tjalling Bosse, Remi A. Nout, 2022, Nature Machine Intelligence.

Mapping use of radiotherapy for patients with non-small cell lung cancer in the Netherlands between 1997 and 2008.

J. Coebergh, C. Koning, M. Janssen-Heijnen, 2012, Clinical oncology (Royal College of Radiologists (Great Britain)).

Prognostic factors in breast-conserving therapy : a prospective population-based cohort study

J. Jobsen, 2010 .

The Mitotic Activity Index in combination with Her2neu: a strong prognosticator in breast cancer

H. Struikmans, J. Jobsen, E. Siemerink, 2020, Breast Cancer Research and Treatment.

Breast-conserving therapy for primary Ductal Carcinoma in Situ in The Netherlands: A multi-center study and population-based analysis.

J. van der Palen, H. Struikmans, J. Jobsen, 2018, Breast.

Explanatory factors for variation in the use of breast conserving surgery and radiotherapy in the Netherlands, 1990-2001.

S. Siesling, L. V. van de Poll-Franse, O. J. Repelaer van Driel, 2007, Breast.

Timing of radiotherapy and survival benefit in breast cancer

F. Ong, J. Jobsen, J. Palen, 2006, Breast Cancer Research and Treatment.

Timed Get Up and Go Test and Geriatric 8 Scores and the Association With (Chemo-)Radiation Therapy Noncompliance and Acute Toxicity in Elderly Cancer Patients.

H. Maas, H. Struikmans, J. V. van Loon, 2017, International journal of radiation oncology, biology, physics.

An actualised population‐based study on the use of radiotherapy in breast cancer patients in the Netherlands

S. Siesling, H. Struikmans, P. Poortmans, 2019, The breast journal.

Prognostic Impact of Breast-Conserving Therapy Versus Mastectomy of BRCA1/2 Mutation Carriers Compared With Noncarriers in a Consecutive Series of Young Breast Cancer Patients.

R. Tollenaar, M. Schmidt, E. Rutgers, 2019, Annals of surgery.

Impaired Geriatric 8 Score is Associated with Worse Survival after Radiotherapy in Older Patients with Cancer.

E. D. Geijsen, H. Maas, H. Struikmans, 2020, Clinical oncology (Royal College of Radiologists (Great Britain)).

QPOLE: A Quick, Simple, and Cheap Alternative for POLE Sequencing in Endometrial Cancer by Multiplex Genotyping Quantitative Polymerase Chain Reaction

J. Khattra, J. McAlpine, C. Gilks, 2023, JCO global oncology.

Breast-conserving therapy versus mastectomy in T1-2N2 stage breast cancer: a population-based study on 10-year overall, relative, and distant metastasis-free survival in 3071 patients

G. H. de Bock, S. Siesling, L. Strobbe, 2016, Breast Cancer Research and Treatment.

Interpretable Deep Learning Predicts the Molecular Endometrial Cancer Classification from H&E Images: A Combined Analysis of the Portec Randomized Clinical Trials

H. Mackay, J. Dijkstra, T. Bosse, 2022, SSRN Electronic Journal.

Radiation therapy combined with hyperthermia versus cisplatin for locally advanced cervical cancer: Results of the randomized RADCHOC trial.

P. Koper, G. V. van Rhoon, H. V. van Doorn, 2016, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Long-term Outcome of the Randomized PORTEC-1 Trial and Quality of Life of the Endometrial Cancer Survivors

W. Putten, R. Nout, J. Mens, 2009 .

L. V. van de Poll-Franse, W. van Putten, R. Nout, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

10 year survival after breast-conserving surgery plus radiotherapy compared with mastectomy in early breast cancer in the Netherlands: a population-based study.

S. Linn, S. Siesling, L. Strobbe, 2016, The Lancet. Oncology.

L. V. van de Poll-Franse, W. van Putten, R. Nout, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Mapping use of radiotherapy for patients with non-small cell lung cancer in the Netherlands between 1997 and 2008.

C. Koning, H. Struikmans, M. Aarts, 2012, Clinical oncology (Royal College of Radiologists (Great Britain)).

Prognostic Impact of Breast-Conserving Therapy Versus Mastectomy of BRCA1/2 Mutation Carriers Compared With Noncarriers in a Consecutive Series of Young Breast Patients Cancer

P. Westenend, S. Siesling, A. J. Broek, 2019 .

Breast-conserving therapy in older patients with breast cancer over three decades: progress or stagnation.

S. Siesling, J. van der Palen, H. Struikmans, 2019, Journal of geriatric oncology.

Treatment results in women with clinical stage I and pathologic stage II endometrial carcinoma

J. van der Palen, J. Jobsen, E. Schutter, 2000, International Journal of Gynecologic Cancer.

Population-based validation study of Adjuvant! for primary breast cancer patients in the Netherlands

S. Siesling, R. Bretveld, C. Groothuis-Oudshoorn, 2016 .

Fifteen-year radiotherapy outcomes of the randomized PORTEC-1 trial for endometrial carcinoma.

L. V. van de Poll-Franse, R. Nout, J. Mens, 2011, International journal of radiation oncology, biology, physics.

Course of Quality of Life After Radiation Therapy for Painful Bone Metastases: A Detailed Analysis From the Dutch Bone Metastasis Study.

F. Oort, C. Marijnen, Y. M. van der Linden, 2016, International journal of radiation oncology, biology, physics.